position: EnglishChannel > Sci-Tech News > Article

Coronavirus vaccine race should put saving lives first

Source: International Communication Center for Science & Technology| 2020-05-06 17:18:13| Author: Lu Zijian, Fang Linlin & China.org
本文来源:http://www.1146633.com/mil_news_sina_com_cn/

申博线路检测登入,1993、1994、1995年的时候,富国投资和IDG等等都是最早的一批创投公司,大家知道北京工体的富国海底世界,当时富国投资的主要是媒体娱乐,当时其实在做文化娱乐的投资方面,除了像海洋工这种娱乐设施,其实我们当时做了很多书刊(《每周电脑报》等等的一些平面媒体),以及当时很早的IT垂直网站。本届大赛一等奖获18万元港元奖金,二等奖、三等奖奖金分别获12万元港元和6万元港元,获奖项目可优先进驻前海深港青年梦工场。  先来说说锅底,年轻人多爱吃辣,甚至无辣不欢。在2015年6月,深华发曾宣布,其将与前深圳市前海中证城市发展管理有限公司及其设立的项目公司就光明旧改项目进行合作,并约定深华发将获得不低于10万平方米的回迁商业物业及5亿元现金等收益。

  从运营的角度看,内容为王更意味着要持续产出的能力,因为大部分的短视频平台都有优质内容生产的可能性,但持续生产是个大问题,而这是实现商业变现的基础,以我们给淘宝电商提供的短视频制作业务为例,商家的要求往往是大批量、标准化的短视频,这对于内容团队的要求,不仅在于创意,更在于一种机构化的生产流程,小的短视频平台没有办法做到。  此外,芒果TV现已形成由互联网电视、手机电视、IPTV、视频网站、移动APP共同构成的“一云多屏”新体系。当然了,现在微软变得更加绅士更加委婉了一些,针对竞争对手的宣传攻势不再那么明显。同时,黔学帮建有今日头条APP“黔学帮”订阅号、贵阳市教育局微博、贵阳网黔学帮网站等,拥有贵阳市教育信息网、贵阳市招考网两个教育系统官方网站。

在本周一也有消息称,该公司正在寻求与知名工作室、制片人以及发行商合作,共同将这些游戏系列制作出英语电影、电视剧,并在世界范围内上映。然而,AppAnnie预计2016年这一数字不增反降为570,相较于2015年下跌7.6%。  中国电子商务行业联盟是由中国电子商务行业门户网站和企业、行业前沿专家学者、行业领袖、企业精英组成的全国性商会组织。正是建立在服务和品质有保障的基础上,碧桂园物业才能实现规模的扩张,这也是未来进一步做大的基础。

A worker of CNBG is testing the illuminance in the workshop where the inactivated vaccine is being tested.(Photo by Zhang Yuwei, Xinhua News)

(Photo/Xinhua)

Wall Street Journal published an opinion article on April 27 stating that, while China's vaccine development is making rapid progress, "America needs to win the coronavirus vaccine race."

The vaccine is considered the most powerful weapon to defeat the coronavirus. Scientists worldwide are racing against time to develop the vaccine.

On March 16, the U.S. announced that a nucleic acid vaccine began clinical trials. On the same day, Chen Wei, a top epidemiologist and virologist with China's Academy of Military Medical Sciences, was authorized to start a clinical trial with an adenovirus vector vaccine, and injected it into the body of a volunteer for the first time. At the end of March, Israel announced breakthroughs in developing vaccines and will soon begin animal testing. In early April, U.S. researchers carried out a patch vaccine test in animals. On April 28, the fourth vaccine in China officially went into clinical trials.

The race to develop the vaccine raised concerns of the WSJ article's author, former U.S. FDA commissioner Scott Gottlieb. He wrote that the FDA should cooperate with corporations to begin safety tests at the early stage to save time, while carrying out vaccine assessment and animal tests in the laboratory at the same time. The article said the first nation to develop a vaccine for COVID-19 could have an economic advantage, and thus will be the first to restore its economy and global influence.

I think the article's perspective of “whoever gets the vaccine gets the world” stands at a low position.

The pandemic is spreading worldwide, and has become a global issue beyond a specific country or region. Countries around the world should work together to push for the development of vaccines and let them benefit the whole world. The success in developing vaccines should not be narrowly connected with national competition and economic recovery.

China is a forerunner in developing the vaccine, which relies on its strong leadership and solidarity in the fight against the virus.

With coordinated efforts by scientific researchers in different sectors, China has promoted information sharing and joint experiments, moving the development of multiple vaccines toward a new stage. At the same time, companies specialized in vaccine R&D also played a part. In the early stage of the outbreak in China, China CDC reached a consensus with some corporations on joint efforts to invest in vaccine R&D, which ensured large-scale productivity of vaccines at a later time. Moreover, many volunteers have also taken part in clinical trials, thus providing ample samples for vaccine R&D, and helping to reduce errors.

China has always upheld the concept of international cooperation, which won recognition from the WHO and the international scientific community.

When a seminar on global research and innovation on COVID-19 was held in early February, the WHO called on the international community to join the formulation of the "scientific research roadmap" for COVID-19, so as to promote the process of diagnosis, treatment, and vaccine development. In mid-April, an expert group made up of more than 120 scientists, physicians, sponsors, and manufacturers from around the world publicly announced that they are committed to joining efforts to speed up the development of vaccines under the WHO coordination.

China has always stuck to the concept of building the community of a shared future for mankind, which is also practiced by Chinese scientists when they are endeavoring to develop the vaccine. No matter which country wins the race, the country should shoulder the responsibility of getting people's life back on track. Tracing the origin and saving lives are the real motivation behind the development, and also the original aspiration and mission for the global scientific community to move forward together.

(You can also read this at: 申博线路检测登入/www_china_org_cn/china/special_coverage/2020-05/06/content_76011049.htm)

Editor:Lu Zijian

Top News

Israel-China Innovation Cooperation Benefits All

China is a model for making its vision to lead global innovation.China leads the development of infrastructure for an advanced technological environment, and the number of its people’s use of technologies and applications increases every year. In many fields, China is also a role model for global innovation.

A Future to Expect: International S&T Community Expresses High Hope in Cooperation with Peers in China English

According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.

ICGEB Accepted 20,000 Protective Face Masks Donation from Chinese Partners

The ICGEB in Trieste, Italy has received a consignment of protective masks from its Chinese partners in Beijing and Taizhou, for distribution?to the local health authorities.

Copyright ? Science and Technology Daily, All Rights Reserved

mailto: yuhy@申博线路检测登入 www.1146633.com

申博提款最快登入 重庆申博官网登入 申博安卓手机下载登入 申博游戏中心直营网 菲律宾太阳娱乐官方网址 菲律宾太阳网a99.com
申博桌面版下载直营网 太阳申博开户登入 申博游戏网直营网 太阳城亚洲游戏登入 申博代理官网登入 www.shenbo2.com
申博线路检测 申博太阳城登入 菲律宾太阳娱乐网址登入 申博游戏网站直营网 菲律宾申博游戏登入 太阳城现金网